Abbott Laboratories (ABT) Assets Average (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Assets Average data on file, last reported at $98.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 21.05% year-over-year to $98.6 billion; the trailing twelve-month figure through Mar 2026 stood at $98.6 billion (up 21.05% YoY), and the FY2025 full-year result was $84.1 billion, up 8.73% from the prior year.
• Assets Average grew to $98.6 billion in Q1 2026, from $85.4 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $98.6 billion in Q1 2026 to a low of $40.4 billion in Q4 2022.
• A 5-year average of $71.7 billion and a median of $73.6 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average jumped 79.86% in 2023 and declined 1.13% in 2024, its largest moves.
• Tracing ABT's Assets Average over 5 years: stood at $40.4 billion in 2022, then jumped by 79.86% to $72.7 billion in 2023, then gained by 7.2% to $77.9 billion in 2024, then gained by 9.71% to $85.4 billion in 2025, then grew by 15.36% to $98.6 billion in 2026.
• Business Quant data shows ABT's Assets Average at $98.6 billion in Q1 2026, $85.4 billion in Q4 2025, and $84.1 billion in Q3 2025.